Americhem Launches EcoLube™ MD PFAS-Free Internally Lubricated Compounds for Healthcare Applications
Americhem, Inc., a globally recognized designer and manufacturer of custom color masterbatch, functional additives, engineered compounds, and performance technologies, has launched the EcoLube™ MD line of PFAS-free internally lubricated compounds specifically for medical devices and other healthcare applications.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250129921412/en/
EcoLube™ MD Pre-lubricated Engineered Compounds (Photo: Business Wire)
Building on the success of Americhem’s launch of EcoLube™ in 2024, EcoLube™ MD offers significant advantages for healthcare applications. As a sustainable, non-PFAS solution, EcoLube™ MD addresses the critical need for effective wear and friction reduction. It ensures compliance with current and future regulations, demonstrates environmental stewardship, and reduces environmental impact.
EcoLube™ MD pre-lubricated engineered compounds and alloys are designed to help manufacturers reduce the wear and friction of moving plastic parts, reduce noise during use, and decrease the coefficient of friction for plastic-on-plastic and plastic-on-metal applications, all without the use of PFAS components. End-use applications can include minimally invasive surgical devices, syringe pumps, prosthetics, surgical robots, and more.
Matt Miklos, Vice President/General Manager of Americhem’s engineered compounds division, noted that healthcare OEMs are increasingly concerned about sustainability and ensuring that new products meet current and future regulations.
“With regulations around the world potentially restricting or banning the use of PFAS and PTFE, healthcare OEMs are challenged with finding alternatives that can match their self-lubricating performance,” said Miklos. “Our new PFAS-free EcoLube™ MD line showcases Americhem's dedication to innovation, meeting their unique needs and helping them stay ahead in their respective markets.”
Enhancing Medical Devices with Rigorous Material Performance and Compliance
Linda Boyett, Vice President of Global Technology & Innovation at Americhem, said Ecolube™ MD has undergone testing for performance and biocompatibility. Internal testing has indicated similar performance to the more traditional internal lubricants and wear resistant additives in most cases. Ecolube™ MD has undergone ISO10993 –5 testing for biocompatibility as part of the global medical compliance certifications.
“ISO10993 – 5 testing for biocompatibility is an important global medical compliance certification, and we’re proud that EcoLube™ MD is a proven solution that supports sustainability and performance for the healthcare industry,” said Boyett.
EcoLube™ Family of Lubricants
EcoLube™ shatters the limitations of conventional lubrication, ushering in a new era of embedded performance. This revolutionary technology integrates specially designed functional additives directly into the material, providing long-lasting lubrication from within. A variety of functional additives cater to specific applications, resulting in a versatile EcoLube™ product line capable of tackling a wide range of lubrication challenges.
- Solid state, non-migrating lubricants that stand up to extreme pressures, reducing frictional wear and "slip-stick" behavior in nylon bearings.
- Multifunctional, migrating, boundary lubricants reduce the coefficient of friction and wear rate by providing immediate lubrication at start-up and high speeds.
- Non-traditional formulations offer shear reinforcement and abrasion resistance between moving, mating parts.
- Low friction, non-migratory additives are designed to offset PTFE in various applications and thermoplastics.
- Ecolube™ MD biocompatibility testing and compliance with the medical certifications are coupled with AEC’s stringent Process Change Management commitments and locked formulation promise make it an easy choice for a variety of medical applications.
A Wide Range of Base Resins
Americhem has formulated EcoLube™ compounds in a wide variety of base resins, including ABS, PBT, PCABS, PC, PEI, PPE, PPS, PE, PP, PSU, PPSU, POM, PEEK, PPA, PA, and TPU.
“We pride ourselves on our ability to customize products to fit end-market performance, conversion processes, color, and aesthetic requirements. By working closely with our customers, we shape specifications and new technologies to meet their unique needs and sustainability objectives,” added Miklos.
About Americhem
Americhem is an innovative, technology-driven leader in the global polymer industry. Its foundation is built around delivering Performance, Solutions and Trust through close collaboration with customers. All of the company's products are backed by complete technical support that ensures quality, reliability, and value. Americhem operates 10 manufacturing plants and maintains sales offices throughout the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250129921412/en/
Contacts
Stephanie Sulcer
Director, Marketing & Communications
sasulcer@americhem.com
+1 (330) 810-0977
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Digital Prosperity Awards Winners Announced at 4 th General Assembly of the Digital Cooperation Organization20.2.2025 23:09:00 CET | Press Release
The Digital Cooperation Organization (DCO), the world's first standalone international intergovernmental organization focusing on the acceleration of the growth of an inclusive and sustainable digital economy, has unveiled the winners of the Digital Prosperity Awards at a ceremony held at its 4th General Assembly gala dinner hosted by the Hashemite Kingdom of Jordan, in the Dead Sea. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250220587577/en/ Digital Prosperity Awards winners announced at 4th General Assembly of the Digital Cooperation Organization (Photo: AETOSWire) Attended by high-level delegations from DCO’s 16 Member States, as well as DCO’s Observers, Partners, and distinguished guests, the Awards aim to acknowledge exceptional initiatives in adopting best practices, policies, and strategies to accelerate digital transformation in their respective countries. The objective is to accelerate digital economic advanceme
IFF Announces Executive Leadership Team Aligned With New Operating Model20.2.2025 22:30:00 CET | Press Release
IFF (NYSE: IFF) announced changes to its executive leadership team, aligned with the Company’s external reporting structure. After 21 years of dedicated service to IFF, Simon Herriott, president of Health and Biosciences, will step down. Effective March 1, Leticia Gonçalves, ADM’s president of precision fermentation and ADM Ventures, will join IFF as president of Health and Biosciences. “Since 2019, Simon has driven growth and operational effectiveness through innovation, customer intimacy and supply chain development as president of our Health and Biosciences business unit,” said Erik Fyrwald, IFF CEO. “We’re grateful for Simon’s tremendous contributions to IFF and wish him well for the future. His dedication and leadership will leave a lasting impact on our organization.” Gonçalves brings to IFF extensive experience with IFF’s end markets in innovation-based companies, having served in various senior global and regional P&L leadership roles at ADM, Bayer and Monsanto in Brazil, Europ
EnerSys to Preview New Battery Energy Storage System and Next Generation Charger at LogiMAT and ProMat 202520.2.2025 22:23:00 CET | Press Release
EnerSys(NYSE: ENS), a global leader in stored energy solutions for industrial applications, will preview their new NexSys™ BESS energy storage system and Synova™ Sync charger concepts at upcoming LogiMAT and ProMat trade shows. These advanced technologies will help operations better manage energy supply and costs – enhancing operational resilience amidst the global energy transition. These new innovations enable organizations to more efficiently store and utilize energy from time- and condition-dependent renewable sources such as wind and solar. The NexSys™ BESS energy storage system also enables operations to better manage energy costs via “peak shaving” from the traditional electric grid – storing energy during periods with lower utility rates for use during periods with higher rates. The advanced Synova™ Sync charger delivers exceptional efficiency and charging performance, featuring two-way data and energy flow capabilities that allow operations to pull energy from equipment back i
atsec Becomes the First Accredited EUCC Conformity Assessment Body20.2.2025 22:20:00 CET | Press Release
atsec is thrilled to announce it is the first accredited conformity assessment body (CAB) for the new EU Common Criteria (EUCC) certification scheme. With this accreditation, atsec can provide evaluations for the Substantial assurance level immediately, the High assurance level once authorization is received shortly, as well as post-certification compliance support. This harmonized approach to security certification is a major milestone, as the EUCC represents an evolution in cybersecurity regulations in the EU and a crucial requirement for ICT product manufacturers. atsec is a Conformity Assessment Body that provides both Information Technology Security Evaluation Facility (ITSEF) and Certification Body (CB) services, resulting in a seamless end-to-end EUCC certification process for manufacturers. atsec provides: Security evaluations and certification services at the assurance level Substantial and High. Post-certification compliance support to help manufacturers maintain their certif
Celltrion Unveils New Post-Hoc Analyses of LIBERTY Studies at the 20 th ECCO Congress Further Evaluating the Efficacy and Safety of Subcutaneous (SC) Infliximab20.2.2025 17:45:00 CET | Press Release
Celltrion announced new post-hoc analyses of its pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC), at the 20th European Crohn’s and Colitis Organisation (ECCO) Congress showcasing the treatment’s effectiveness across a range of key clinical outcomes in inflammatory bowel disease (IBD). The analyses highlight Celltrion’s ongoing efforts to evaluate the efficacy and safety of subcutaneous (SC) infliximab (CT-P13 SC) in achieving endoscopic-histologic remission in ulcerative colitis (UC), clinical and endoscopic improvement across all disease locations in Crohn’s disease (CD), and supporting early clinical recapture after dose escalation following loss of response in CD and UC, and long-term drug persistence regardless of ADA in CD patients.3,4,5,6 LIBERTY-UC Phase III Post-Hoc Analysis (LIBERTY-UC Endo-Histological Outcome) A post-hoc analysis of the Phase 3 LIBERTY-UC study showed that maintenance therapy with SC infliximab resulted in significantly greater improvements in endoscopic
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom